This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2002 Mar 20;94(6):406-7.

doi: 10.1093/jnci/94.6.406.

Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus

Rajnish A Gupta, Raymond N DuBois

PMID: 11904306
DOI: 10.1093/jnci/94.6.406

Editorial

Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus

Rajnish A Gupta et al. J Natl Cancer Inst. 2002.

. 2002 Mar 20;94(6):406-7.

doi: 10.1093/jnci/94.6.406.

Authors

Rajnish A Gupta, Raymond N DuBois

PMID: 11904306
DOI: 10.1093/jnci/94.6.406

No abstract available

PubMed Disclaimer

Comment on

The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.
Buttar NS, Wang KK, Anderson MA, Dierkhising RA, Pacifico RJ, Krishnadath KK, Lutzke LS. Buttar NS, et al. J Natl Cancer Inst. 2002 Mar 20;94(6):422-9. doi: 10.1093/jnci/94.6.422. J Natl Cancer Inst. 2002. PMID: 11904314

Similar articles

[Medical treatment of Barrett's esophagus].
Kinoshita Y, Yuki T. Kinoshita Y, et al. Nihon Rinsho. 2005 Aug;63(8):1449-53. Nihon Rinsho. 2005. PMID: 16101238 Review. Japanese.
COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N. Altorki N. J Surg Res. 2004 Mar;117(1):114-20. doi: 10.1016/j.jss.2003.12.005. J Surg Res. 2004. PMID: 15013721 Review. No abstract available.
[The clinical strategy for the Barrett's esophagus].
Kitabatake S, Niwa Y, Goto H. Kitabatake S, et al. Nihon Rinsho. 2005 Aug;63(8):1434-7. Nihon Rinsho. 2005. PMID: 16101235 Review. Japanese.
Does chemoprevention of Barrett's esophagus using acid suppression and/or COX-2 inhibition prevent neoplastic progression?
Fennerty MB. Fennerty MB. Rev Gastroenterol Disord. 2002;2 Suppl 2:S30-7. Rev Gastroenterol Disord. 2002. PMID: 12478242
The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.
Buttar NS, Wang KK, Anderson MA, Dierkhising RA, Pacifico RJ, Krishnadath KK, Lutzke LS. Buttar NS, et al. J Natl Cancer Inst. 2002 Mar 20;94(6):422-9. doi: 10.1093/jnci/94.6.422. J Natl Cancer Inst. 2002. PMID: 11904314

See all similar articles

Cited by

Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.
Paul AG, Chandran B, Sharma-Walia N. Paul AG, et al. Transl Res. 2013 Jun;161(6):447-68. doi: 10.1016/j.trsl.2013.02.008. Epub 2013 Mar 20. Transl Res. 2013. PMID: 23523954 Free PMC article.
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.
Galipeau PC, Li X, Blount PL, Maley CC, Sanchez CA, Odze RD, Ayub K, Rabinovitch PS, Vaughan TL, Reid BJ. Galipeau PC, et al. PLoS Med. 2007 Feb;4(2):e67. doi: 10.1371/journal.pmed.0040067. PLoS Med. 2007. PMID: 17326708 Free PMC article.
Fluorocoxib A loaded nanoparticles enable targeted visualization of cyclooxygenase-2 in inflammation and cancer.
Uddin MJ, Werfel TA, Crews BC, Gupta MK, Kavanaugh TE, Kingsley PJ, Boyd K, Marnett LJ, Duvall CL. Uddin MJ, et al. Biomaterials. 2016 Jun;92:71-80. doi: 10.1016/j.biomaterials.2016.03.028. Epub 2016 Mar 21. Biomaterials. 2016. PMID: 27043768 Free PMC article.
Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.
Thrift AP, Anderson LA, Murray LJ, Cook MB, Shaheen NJ, Rubenstein JH, El-Serag HB, Vaughan TL, Schneider JL, Whiteman DC, Corley DA. Thrift AP, et al. Am J Gastroenterol. 2016 Nov;111(11):1528-1535. doi: 10.1038/ajg.2016.348. Epub 2016 Aug 30. Am J Gastroenterol. 2016. PMID: 27575711 Free PMC article.
Design, synthesis, and structure-activity relationship studies of fluorescent inhibitors of cycloxygenase-2 as targeted optical imaging agents.
Uddin MJ, Crews BC, Ghebreselasie K, Marnett LJ. Uddin MJ, et al. Bioconjug Chem. 2013 Apr 17;24(4):712-23. doi: 10.1021/bc300693w. Epub 2013 Mar 28. Bioconjug Chem. 2013. PMID: 23488616 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program